Canadian experience with implementation of an acellular pertussis vaccine booster-dose program in adolescents: Implications for the United States

Pediatric Infectious Disease Journal

Volumn 24, Issue 6 SUPPL., 2005, Pages

  Halperin, Scott A ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Acellular pertussis vaccine; Adolescent; Booster; Implementation

Indexed keywords

ACELLULAR VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE;

ADOLESCENCE; ADOLESCENT; BACTERIAL INFECTION; CANADA; CHILD HEALTH CARE; DIPHTHERIA; DRUG FORMULATION; FAMILY MEDICINE; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH PROGRAM; HEPATITIS B; HUMAN; IMMUNIZATION; MORBIDITY; PEDIATRICIAN; PERTUSSIS; PNEUMONIA; POLIOMYELITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVACCINATION; REVIEW; TETANUS; UNITED STATES; URINE INCONTINENCE; VACCINATION; VIRUS INFECTION;

ADOLESCENT; ADULT; CANADA; CHILD; CHILD, PRESCHOOL; CONSENSUS DEVELOPMENT CONFERENCES; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DISEASE OUTBREAKS; DRUG APPROVAL; HUMANS; IMMUNIZATION, SECONDARY; INCIDENCE; NATIONAL HEALTH PROGRAMS; PRACTICE GUIDELINES; UNITED STATES; WHOOPING COUGH;

EID: 20544438654     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000166163.02135.8b     Document Type: Review

References (38)

1. Public Health Agency of Canada. Vaccine-preventable diseases: pertussis. Available at: http://www.phac-aspc.gc.ca/dird-dimr/vpd-mev/ pertussis_e.html. Accessed January 13, 2005.
2. Skowronski DM, De Serres G, MacDonald D, et al. The changing age and seasonal profile of pertussis in Canada [published correction appears in J Infect Dis. 2002;185:1696]. J Infect Dis. 2002;185:1448-1453.
3. Ntezayabo B, De Serres G, Duval B. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr Infect Dis J. 2003;22:22-27.
4. De Serres G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis. 2000;182:174-179.
5. Skowronski DM, Buxton JA, Hestrin M, Keyes RD, Lynch K, Halperin SA. Carotid artery dissection as a possible severe complication of pertussis in an adult: clinical case report and review. Clin Infect Dis. 2003;36:e1-e4. Available at: http://www.journals.uchicago.edu/CID/ journal/issues/v36n1/020600/ 020600.html. Accessed January 2, 2003.
6. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B, the Sentinel Health Unit Surveillance System Pertussis Working Group. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis. 2001;32:1691-1697.
7. Aventis Pasteur. Adacel™ prescribing information. Toronto, Ontario, Canada: sanofi pasteur; 2002.
8. Halperin SA, Smith B, Russell M, et al. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine. 2000;18:1312-1319.
9. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine [published correction appears in N Engl J Med. 1996;334:1207]. N Engl J Med. 1996;334:349-355.
10. Olin P, Rasmussen F, Gustafsson L, Hallander HO, Heijbel H. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine [published correction appears in Lancet. 1998;351: 454]. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet. 1997;350:1569-1577.
11. Halperin SA, Smith B, Russell M, et al. Adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults. Pediatr Infect Dis J. 2000;19:276-283.
12. National Advisory Committee on Immunization (NACI). Statement on adult/adolescent formulation of combined acellular pertussis, tetanus, and diphtheria vaccine. Can Commun Dis Rep. 2000;26:1-8.
13. Laboratory Centre for Disease Control. Consensus conference on measles. Can Commun Dis Rep. 1993;19:72-79.
14. Laboratory Centre for Disease Control. Guidelines for control of meningococcal disease: Canadian consensus conference on meningococcal disease. Can Med Assoc J. 1994;150:1825-1839.
15. Laboratory Centre for Disease Control. Proceedings of the National Varicella Consensus Conference. Can Commun Dis Rep. 1999;25 (suppl):S5.
16. Laboratory Centre for Disease Control. Mumps and Rubella Consensus Conference. Can Commun Dis Rep. 1994;20:165-176.
17. Laboratory Centre for Disease Control. Canadian Consensus Conference on Influenza. Can Commun Dis Rep. 1993;19:136-142, 145-147.
18. Laboratory Centre for Disease Control. Preventing pneumococcal disease: a Canadian consensus conference. February 16-18, 1998. Can Commun Dis Rep. 1999;25:25-35.
19. Laboratory Centre for Disease Control. Pertussis consensus conference. Can Med Assoc J. 1994;150:1625-1630.
20. Canadian Medical Association. Canadian Immunization Guide. 2nd ed. Ottawa: Health Canada; 1984.
21. Canadian Medical Association. Canadian Immunization Guide. 6th ed. Ottawa. Ontario, Canada: Health Canada; 2002.
22. National Advisory Committee on Immunization (NACI). Prevention of pertussis in adolescents and adults. Can Commun Dis Rep. 2003;29:1-9.
23. MacDonald N, Embree J. Access to vaccines: A call to action [editorial]. Can J Infect Dis. 2003;14:9-10,
24. and Paediatr Child Health. 2003;8: 11-12.
25. Pollard AJ, Bigham JM, Shaw E, et al. Meningococcal disease in British Columbia. BC Med J. 2001;43:21-27.
26. Sweet L, Gallant P, Morris M, Halperin SA. Canada's first universal varicella immunization program: lessons from Prince Edward Island. Can J Infect Dis. 2003;14:41-44.
27. Schabas R. Adolescent and adult pertussis: a problem and a solution. Can Fam Physician. 2000;46:2169-2170,2176-2177.
28. Infectious Diseases and Immunization Committee, Canadian Paediatric Society (CPS). Acellular pertussis vaccine for adolescents. Paediatr Child Health. 2003;8:378.
29. F/P/T Advisory Committee on Population Health and Health Security (ACPHHS). National Immunization Strategy: Final Report 2003. Public Works and Government Services Canada. Catalog no. H39-4/15-2003.
30. David ST, Hemsley C, Pasquali PE, Larke B, Buxton JA, Lior LY. Adolescent catch-up: dTap three years after tetanus toxoid, Yukon 2004 [abstract 010]. Paper presented at: 6th Canadian Immunization Conference; Montreal, Quebec, Canada; December 5-8, 2004.
31. Gellin BG, Maibach EW, Marcuse EK. Do parents understand immunizations? A national telephone survey. Pediatrics. 2000;106:1097-1102.
32. Dionne M, Boulianne N, Duval B, et al. Lack of conviction about vaccination in certain Quebec vaccinators. Can J Public Health. 2001; 92:100-104.
33. Kandola K, Lea A, Santos M. Pertussis rates in Northwest Territories after introducing adult formulation acellular vaccine [abstract P7]. Paper presented at: 6th Canadian Immunization Conference; Montreal, Quebec, Canada; December 5-8, 2004.
34. Patrick DM, Bigham M, Ng H, White R, Tweed A, Skowronski DM. Elimination of acute hepatitis B among adolescents after one decade of an immunization program targeting Grade 6 students. Pediatr Infect Dis J. 2003;22:874-877.
35. Gilberg S, Njamkepo E, Du Chatelet IP, et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J Infect Dis. 2002; 186:415-418.
36. Campins-Martí M, Cheng HK, Forsyth K, et al. International Consensus Group on Pertussis Immunisation. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine. 2001;20:641-646.
37. Wirsing von König CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis. 2002;2:744-750.
38. Andrews R, Herceg A, Roberts C. Pertussis notifications in Australia, 1991 to 1997. Commun Dis Intell. 1997;21:145-148.